Teclistamab-cqyv is a T-cell-engaging bispecific antibody that targets multiple myeloma cells via the B-cell maturation ...

NASA’s SLS rocket and Orion programs received significant funding after previously being on the chopping block for NASA budget cuts.

Duality Biotherapeutics' ('DualityBio', HKEX:09606) partner Avenzo Therapeutics, Inc. ('Avenzo'), a clinical-stage biotechnology company developing next-generation oncology therapies, today announced ...